Andrew Allen - Insider Trading & Ownership

Entity
Individual
Location
2525 28 Th Street, Suite 200, Boulder, CO
Summary
The estimated net worth of Andrew Allen is at least $1.85M dollars as of July 1, 2024. Andrew Allen is the PRESIDENT AND CEO, Director of Gritstone bio, Inc. and owns shares of Gritstone bio, Inc. (GRTS) stock worth about $1.82M. Andrew Allen is the Director of Epizyme, Inc. and owns shares of Epizyme, Inc. stock worth about $29K.
All Insider Reports
All Insider Reports

Ownership of Andrew Allen

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
GRTS Gritstone bio, Inc. PRESIDENT AND CEO, Director $1.82M -$18.2K -0.99% Jun 24, 2024
EPZM Epizyme, Inc. Director $29K Jun 11, 2021
ADAP Adaptimmune Therapeutics PLC Director Jul 1, 2024
SRRA Sierra Oncology, Inc. Director, 10%+ Owner Jul 1, 2022
TCRR TCR2 THERAPEUTICS INC. Director Jun 1, 2023

Insider Transactions Reported by Andrew Allen:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.